LONDON GlaxoSmithKline plans to split into two businesses -- one for prescription drugs and vaccines, the other for over-the-counter products -- after forming a new joint venture with Pfizer's consumer health division. | Video
LONDON GlaxoSmithKline has agreed to buy U.S. cancer specialist Tesaro for $5.1 billion, a costly investment to rebuild the pharmaceuticals business by new Chief Executive Emma Walmsley that unnerved investors. | Video
LONDON Unilever is to buy GlaxoSmithKline's Horlicks nutrition business for $3.8 billion (2.98 billion pounds), boosting the Anglo-Dutch group's position in India by adding the popular malted drink.
LONDON A global diabetes epidemic is fuelling record demand for insulin but tens of millions will not get the injections they need unless there is a dramatic improvement in access and affordability, a new study concluded on Wednesday.
LONDON Many of the world's top drugmakers are not doing enough to provide medicines to poor countries, leaving big gaps in access to treatments in crucial disease areas, including cancer, according to a new report on Tuesday.
LONDON U.S. medical device maker Boston Scientific Corp has agreed to buy Britain's BTG Plc for 3.3 billion pounds ($4.24 billion) in cash, adding technology to fight cancer and other serious diseases to its portfolio.
Russian President Vladimir Putin said after holding his first face-to-face talks with North Korean leader Kim Jong Un on Thursday that U.S. security guarantees would probably not be enough to persuade Pyongyang to shut its nuclear programme.